The Cambridge Technology and Life Sciences team advised Lindus Health on their $55 million Series B round. The round was led by Balderton Capital, with support from Creandum, Firstminute, Seedcamp and Visionaries Club.
Lindus Health provides fully integrated clinical trial management services and in-house trial management technology.
The Goodwin team included Elizabeth Rhodes and Ciara Kendall.
For additional details on the financing please see here.